FINANCIAL EFFECTS The MOU will not have any effect on the issued and paid up shares capital of BKCB but the estimated gross development value of the Proposed Development is expected to contribute positively towards the future earnings of BKCB Group
Bintai Kinden subsidiary inks MOU for Covid-19 vaccine distribution in Australia, New Zealand TheEdge Thu, Nov 12, 2020 02:19pm - 12 minutes ago
KUALA LUMPUR (Nov 12): Bintai Kinden Corp Bhd's majority-owned subsidiary Bintai Healthcare Sdn Bhd (BHSB) today signed a memorandum of understanding (MOU) with Australia-listed International Equities Corp Ltd's (IEC) wholly owned subsidiary IEC Properties Pty Ltd under a planned arrangement for which IEC will have the sole distribution rights for a Covid-19 vaccine in Australia and New Zealand.
According to Bintai Kinden's filing with Bursa Malaysia today, the MOU enables BHSB and IEC to further negotiate the terms and conditions wherein IEC will be sub-licensed by BHSB to supply the Ii Key-SARS-CoV-2 vaccine in Australia and New Zealand.
0.73 got huge volume just to upload private placement share at 0.735. 31,8000,000 units listed today at 0.565. The private investor already make 30% gain. Let see tomorrow whether this 0.730 buyer will come in or not.
On the Covid-19 vaccine and development, he also thanked China’s contribution and support for Asean’s initiatives for public health emergencies.
“We look forward to the swift completion of the clinical trials of the vaccine, and appreciate (China’s) President Xi Jinping’s pledge to make the vaccine a ‘global public good’.
“On that note, Malaysia is appreciative of China’s commitment to prioritise Malaysia as a recipient, and we are now ready to receive successfully developed Covid-19 vaccines,” he said.
Chinese companies could still emerge as frontrunners in vaccine distribution: The inactivated vaccines would be easier to distribute in poorer countries than the double-shot from Pfizer, which requires costly deep-freeze production, storage and transportation networks.
In stock market we belive in history will repeat, please check on what happened on 21st and 22nd Sept. Announcement made on 21st lunch break, share price slightly drop, close with small doji, then the next day price up! Today announcement also made during lunch break, so tomorrow will history repeat and banker use the same tatic? Let's see.
Morocco presses ahead with vaccine campaign preparations
In implementation of Royal guidelines to roll out coronavirus vaccine for all, head of the government Saad Eddine El Othmani said that preparations are underway and the safety and health of citizens is a priority.
“Our country’s choice for a vaccine is based on the criteria of safety and efficiency,” said El Othmani at the weekly cabinet meeting held Thursday.
THE TRIALS HAVE SHOWN THE VACCINE TO BE ADOPTED BY MOROCCO TO BE SAFE AND EFFICIENT, HE SAID, ADDING THAT MOROCCO WORKS IN CLOSE COOPERATION WITH THE WORLD HEALTH ORGANIZATION to that end.
Morocco had taken part in trials for the Chinese SINOPHARM vaccine and has ordered doses of the R-Pharm vaccine developed under a contract from the UK’s AstraZenica, which produced a vaccine in collaboration with Oxford University.
Exclusive: Indonesia to start mass COVID-19 vaccination THIS YEAR - President
Indonesia has sought emergency authorisation to start a mass vaccination campaign BY THE END OF THE YEAR to combat the coronavirus in the archipelago, the Southeast Asian nation’s president said on Friday.
In an interview with Reuters, President Joko Widodo, commonly known as Jokowi, said plans were already advanced to distribute the vaccine across the entire country.
Vaccines produced by China’s Sinovac and SINOPHARM are slated to be used in the early stages of the campaign. This year, the companies will provide 18 million vaccines, including 15 million that will be manufactured by Indonesia’s state-owned pharmaceutical company Bio Farma.
China National Pharmaceutical Group Corp (SINOPHARM), a Chinese state-owned enterprise, announced on Wednesday that data from late-stage clinical trials for its Covid-19 vaccine are «BETTER THAN EXPECTED», Reuters reported.
In Morocco, Dr. Abdelhakim Yahyane, a member of the National Scientific Advisory Committee on Vaccination, told Yabiladi earier this week that vaccine trials in the country «have REACHED THE FINAL PHASE».
We are impatiently awaiting the end of this process, which could probably happen BY NEXT WEEK
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
azri28
34 posts
Posted by azri28 > 2020-11-12 12:47 | Report Abuse
Bintai big news lorr. With another listed company.